SCHEMBL19797646

SCHEMBL19797646

Cn1c2ccccc2c2ccc(Cc3ccc4c5ccc6c(c7ccccc7n6C)c5n(C)c4c3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
HPGD P15428 4/20 0.52
ALDH1A1 P00352 3/20 0.52
HSD17B10 Q99714 2/20 0.52
MAPT P10636 6/20 0.49
TSHR P16473 1/20 0.49
GPR3 P46089 1/20 0.46
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797657 1.00 KDM4E (0.52) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797656 0.97 KDM4E (0.50) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797674 0.97 KDM4E (0.50) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797664 0.97 KDM4E (0.50) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797665 0.96 KDM4E (0.51) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19652579 0.94 KDM4E (0.46) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19652578 0.91 KDM4E (0.46) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797645 0.91 KDM4E (0.57) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797641 0.88 KDM4E (0.55) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL19797644 0.88 KDM4E (0.55) KDM4EHPGDALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed
US-20180026205-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 KDM4E 4531/4885HPGD 986/4885ALDH1A1 156/4885
US-20180026205-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OR51E2, OXER1 KDM4E 4452/4885HPGD 1323/4885ALDH1A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.